These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6990672)

  • 1. The role of insulin absorption and sensitivity in determining a diabetic's daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Smythe P; Alberti KG
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):190-5. PubMed ID: 6990672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired subcutaneous absorption of insulin in 'brittle' diabetics.
    Home PD; Massi-Benedetti M; Gill GV; Capaldo B; Shepherd GA; Alberti KG
    Acta Endocrinol (Copenh); 1982 Nov; 101(3):414-20. PubMed ID: 6756010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic response to moderate exercise in diabetic man receiving intravenous and subcutaneous insulin.
    Murray FT; Zinman B; McClean PA; Denoga A; Albisser AM; Leibel BS; Nakhooda AF; Stokes EF; Marliss EB
    J Clin Endocrinol Metab; 1977 Apr; 44(4):708-20. PubMed ID: 849981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.
    Castillo M; Nemery A; Verdin E; Lefebvre PJ; Luyckx AS
    Eur J Clin Pharmacol; 1983; 25(6):767-71. PubMed ID: 6363099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics.
    Gale EA; Tattersall RB
    Lancet; 1979 May; 1(8125):1049-52. PubMed ID: 86775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma glucose and plasma free insulin during CSII and intensified conventional insulin therapy.
    Buysschaert M; Marchand E; Ketelslegers JM; Lambert AE
    Diabetes Care; 1983; 6(1):1-5. PubMed ID: 6341010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose insulin infusions in diabetic patients with high insulin requirements.
    Dandona P; Foster M; Healey F; Greenbury E; Beckett AG
    Lancet; 1978 Aug; 2(8084):283-5. PubMed ID: 79081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for multiple subcutaneous insulin injections developed from individual diabetic patient data.
    Puckett WR; Lightfoot EN
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1115-24. PubMed ID: 8572205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved serum insulin profiles in diabetic individuals who massaged their insulin injection sites.
    Dillon RS
    Diabetes Care; 1983; 6(4):399-401. PubMed ID: 6352212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
    Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
    N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy.
    Viberti GC; Home PD; Bilous RW; Alberti KG; Dalton N; Keen H; Pickup JC
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):515-20. PubMed ID: 6372348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.